SomnoMed Limited reported unaudited sales results for the second quarter and six months of 2016. For the quarter, the company reported strong direct sales in the US and Europe resulted in quarterly MAS device revenues of $9.8 million, which were 27.2% higher than in the previous year. Non device revenues including managed dental service fees, cleaning tablets and repair service fees amounted to $3.29 million. Global direct sales of SomnoDent® devices in the second quarter of 2016 recorded a growth of 21.3%. Including licensees sales, a total of 16,151 SomnoDent® devices were sold globally in the second quarter of 2016, 19% above the same quarter in the previous year

SomnoDent® devices sold during the first half year period to 28,997, increased 17% against the same period a year ago. The company announced total revenues generated from the sale of SomnoDent® devices for the first six months of the financial year 2015/16 increased by 30.3%, compared to the previous year, to $18.05 million.